Palatin Technologies, Inc. (PTN)
$8.60-4.55%Close
SELLCRISIS · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $15M
- Beta
- -0.07
- P/E (TTM)
- -1.79
- Short % float
- 26.38%
- Days to cover
- 8.0
- SI change
- +1.0%
- 1W
- -7.82%
- 1M
- -28.45%
- vs SPY 1W
- -8.98%
- vs SPY 1M
- -31.44%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PTN?
- LOPJLB’s latest quantitative signal on Palatin Technologies, Inc. (PTN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PTN in?
- Palatin Technologies, Inc. (PTN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Palatin Technologies, Inc. (PTN) do?
- Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial…